Identity
- Trade Name
- Glycated Serum Protein Linearity Set FDA UDI
- Generic Name
- Fructosamine IVD, control FDA UDI
- Device Name
- Stanbio Glycated Serum Protein (GSP) Linearity Set is intended to be used for quality control procedures in verifying the linearity throughout the reportable range of Stanbio’s Glycated Serum Protein (GSP) LiquiColor®. For in-vitro diagnostic use only. FDA UDI
- Model / Reference
- 2380-201 FDA UDI
- Description
- Stanbio Glycated Serum Protein (GSP) Linearity Set is intended to be used for quality control procedures in verifying the linearity throughout the reportable range of Stanbio’s Glycated Serum Protein (GSP) LiquiColor®. For in-vitro diagnostic use only. FDA UDI
Identifiers
- Catalog Number
- 2380-201 FDA UDI
- Primary DI / UDI-DI
- 00657498001134 FDA UDI
- FDA Product Code
- JJX FDA UDI
- GMDN Term
- Fructosamine IVD, control FDA UDI
Classification
- Device Class
- Class I FDA UDI
- Regulation Number
- 862.1660 FDA UDI
- Commercial Distribution
- Not in Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Glycated Serum Protein Linearity Set by Stanbio Laboratory, L.p. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class I | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Stanbio Laboratory, L.p.
Sources (1)
- FDA UDI 9c8138e4-7a40-443d-b1ae-f7b39e0c3d25 37 fields · synced May 30, 2026